Lee BABISS,Matthew CLARK,Anthony D. KEEFE,Mark J. MULVIHILL,Haihong NI,Louis RENZETTI,Frank RUEBSAM,Ce WANG,Zhifeng XIE,Ying ZHANG
申请号：
US16256429
公开号：
US20190225611A1
申请日:
2019.04.12
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.
